A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride
Yükleniyor...
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Modestum Ltd.
Erişim Hakkı
Attribution 4.0 International (CC BY 4.0)
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature. © 2018 by the authors; licensee Modestum Ltd., UK.
Açıklama
Anahtar Kelimeler
Amisulpride, Atypical Antipsychotics, Electroconvulsive Therapy, Neuroleptic Malignant Syndrome
Kaynak
Electronic Journal of General Medicine
WoS Q Değeri
N/A
Scopus Q Değeri
Q1
Cilt
15
Sayı
3
Künye
Karayağmurlu, A., Karayağmurlu, E., Üstündağ, M. F., Yazla, E. (2018). A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride. Electronic Journal of General Medicine, 15(3).
